BIAL - Portela & CA, S.A.

Portugal


 
Total IP 239
Total IP incl. subs 243 (+ 4 for subs)
Total IP Rank # 5,414
IP Activity Score 2.7/5.0    63
IP Activity Rank # 11,417
Parent Entity Bial - S.G.P.S., S.A
Dominant Nice Class Pharmaceutical, veterinary and s...

Patents

Trademarks

62 19
30 16
68 12
32
 
Last Patent 2025 - Morpholine orexin receptor antag...
First Patent 1996 - Substituted dihydrodibenzo/b,f/a...
Last Trademark 2022 - POLIPRES
First Trademark 1984 - Bial

Subsidiaries

1 subsidiaries with IP (2 patents, 2 trademarks)

2 subsidiaries without IP

 Register for free to unlock the subsidiary list

Industry (Nice Classification)

Latest Inventions, Goods, Services

2024 Invention Morpholine orexin receptor antagonists. The present invention relates to compounds of Formula (I)...
2023 Invention Processes and intermediates for synthesising opicapone. The present invention relates to a method...
Invention Treatment regimens for early idiopathic parkinson's disease. Opicapone for use as adjunctive the...
Invention Treatment regimens for parkinson's disease. A method of treating Parkinson's disease in a patient...
Invention Treatment regimens for early idiopathic parkinson's disease. Opicapone for use as adjunctive ther...
Invention Prodrugs of opicapone. This invention relates to prodrugs of opicapone, their synthetic intermedi...
Invention Medicaments for slowing parkinson's disease. Opicapone, levodopa and an AADC inhibitor are descr...
2022 Invention Dopamine-b-hydroxylase inhibitors. This invention relates to: (a) compounds of formula Ia (with ...
Invention Methods of treatment of partial onset seizures using eslicarbazepine acetate. The present disclo...
Invention Nitrocatechol derivatives as comt inhibitors. New compounds of formula I are described: New co...
G/S Pharmaceutical preparations; Medical preparations; Veterinary preparations; Sanitary preparations...
2021 Invention Treatment regimens for parkinson's disease. Opicapone, or a pharmaceutically acceptable derivati...
Invention Opicapone and levodopa for the treatment of parkinson's disease. Opicapone, or a pharmaceutically...
Invention Treatment of pain associated with parkinson's disease. This invention relates to methods for tre...
Invention Solid dispersion of opicapone. This invention relates to kinetically soluble and bioavailable fo...
Invention Solid dispersion of opicapone. This invention relates to kinetically soluble and bioavailable for...
Invention Tablet comprising opicapone. The present invention provides a tablet comprising opicapone or a p...
Invention Tablet comprising opicapone. The present invention provides a tablet comprising opicapone or a ph...
Invention 1,3-dihydroimidazole-2-thione derivatives as inhibitors of dopamine-beta-hydroxylase. Compounds ...
Invention Methods for the administration of comt inhibitors. Provided are methods of administering a catec...
Invention Particle size control. The present invention relates to micronised pharmaceutical products of cr...
Invention Micronised opicapone. The present invention relates to micronised pharmaceutical products of crys...
Invention Blood-brain barrier-penetrant dopamine-ß-hydroxylase inhibitors. This invention relates to: (a) ...
Invention Pharmaceutical composition comprising licarbazepine acetate. A pharmaceutical composition compri...
Invention Treatment of pain associated with parkinson's disease with opicapone in combination with levodopa...
2020 Invention Pharmaceutical formulations comprising nitrocatechol derivatives and methods of making the same. ...
G/S PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF DISEASES AND DISORDERS OF THE CENTRAL AND PERIPH...
Invention Methods of treatment of partial onset seizures using eslicarbazepine acetate. The present disclos...
Invention Dopamine-b-hydroxylase inhibitors. This invention relates to: (a) compounds of formula I (with R...
Invention Dopamine-b-hydroxylase inhibitors. This invention relates to: (a) compounds of formula I (with R1...
Invention Dopamine-β-hydroxylase inhibitors. 155 and A as defined herein) and pharmaceutically acceptable s...
G/S Providing medical information
Invention Pharmaceutical formulations comprising nitrocatechol derivatives and methods of making thereof. ...
2019 Invention Imidazolecarboxamides and their use as faah inhibitors. A compound having a structure selected f...
G/S providing medical information
G/S Non-medicated cosmetics and toiletry preparations; Non-medicated dentifrices; Perfumery, essentia...
Invention Methods for the administration of comt inhibitors. Provided are methods of administering a catech...
Invention Processes for the synthesis of substituted urea compounds. 2R5 to form a glyoxal intermediate R6-...
Invention Formulations comprising dopamine-b-hydroxylase inhibitors and methods for their preparation. The...
Invention Formulations comprising dopamine-beta-hydroxylase inhibitors and methods for their preparation. T...
Invention Formulations comprising dopamine-β-hydroxylase inhibitors and methods for their preparation. The ...
2018 Invention Dopamine-b-hydroxylase inhibitors. This invention relates to: (a) compounds of formula Ia (with R...
G/S Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes...
G/S Pharmaceutical preparations for the treatment of diseases and disorders of the central and periph...
G/S Pharmaceutical, medical and veterinary preparations; Sanitary preparations for medical purposes;...
2017 Invention Dopamine-β-hydroxylase inhibitors. This invention relates to: (a) compounds of Formula Ia (with R...
Invention Blood-brain barrier-penetrant dopamine-β-hydroxylase inhibitors. 5, n and A as defined herein) an...
G/S Pharmaceutical and veterinary preparations for the treatment of diseases and disorders of the cen...
2016 G/S Pharmaceutical and veterinarian preparations; Sanitary preparations for medical purposes; Dieteti...
2015 G/S Printed materials, namely, periodicals, booklets, brochures, and pamphlets in the fields of disea...
G/S Pharmaceutical products and preparations for the treatment and prevention of diseases and conditi...
G/S Providing medical information relating to ongoing research programs and studies in the fields of ...
2014 G/S Pharmaceutical products and preparations in the nature of eslicarbazepine acetate for the treatme...
2013 G/S Pharmaceutical preparations for the treatment of central nervous system disorders
2011 G/S Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic...
G/S Pharmaceutical and veterinary preparations; Sanitary preparations for medical purposes; Dietetic ...
G/S Pharmaceutical products for the diagnostic, prophylaxis and treatment of allergies; pharmaceutica...
G/S Pharmaceutical preparations; sanitary preparations for medical purposes; dietetic substances adap...